fructose-1,6-diphosphate and Insulin Resistance

fructose-1,6-diphosphate has been researched along with Insulin Resistance in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belfiore, F; Campione, R; Iannello, S; Rabuazzo, AM; Vasta, D	1
Campos, G; Durante, P; Gómez, ME; Raleigh, X; Ryder, E	1

Other Studies

2 other study(ies) available for fructose-1,6-diphosphate and Insulin Resistance

Article	Year
Insulin resistance in the obese hyperglycemic (ob/ob) mouse. Failure of hyperinsulinemia to activate hepatic pyruvate kinase (PK). Metabolism: clinical and experimental, 1984, Volume: 33, Issue:2 Topics: Animals; Enzyme Activation; Fructosediphosphates; Hyperinsulinism; Insulin Resistance; Liver; Mice; Mice, Obese; Pyruvate Kinase	1984
Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals. Biochemical and biophysical research communications, 1996, Aug-23, Volume: 225, Issue:3 Topics: Adenosine Triphosphate; Case-Control Studies; Citrates; Citric Acid; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Fructosediphosphates; Fructosephosphates; Humans; Insulin Resistance; Isoenzymes; Kinetics; Neutrophils; Obesity; Phosphofructokinase-1; Substrate Specificity	1996

Article

Year

Insulin resistance in the obese hyperglycemic (ob/ob) mouse. Failure of hyperinsulinemia to activate hepatic pyruvate kinase (PK).

Metabolism: clinical and experimental, 1984, Volume: 33, Issue:2

Topics: Animals; Enzyme Activation; Fructosediphosphates; Hyperinsulinism; Insulin Resistance; Liver; Mice; Mice, Obese; Pyruvate Kinase

1984

Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.

Biochemical and biophysical research communications, 1996, Aug-23, Volume: 225, Issue:3

Topics: Adenosine Triphosphate; Case-Control Studies; Citrates; Citric Acid; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Fructosediphosphates; Fructosephosphates; Humans; Insulin Resistance; Isoenzymes; Kinetics; Neutrophils; Obesity; Phosphofructokinase-1; Substrate Specificity

1996